The term life sciences still does not have an accurate translation into Portuguese, which is perhaps due to its broad meaning. The life sciences area combines knowledge of biology, pharmacy and chemistry to develop technologies that will be applied to living organisms and biological systems in general, as well as in manufacturing of goods. It is this convergence of expertise and diverse potential that makes life sciences an area that Daniel Legal & IP Strategy will continue to invest in for years to come.
The life science area has faced some specific challenges in Brazil, due to legal prohibitions and certain resolutions of the BPTO. Examples are the prohibition of patents for all living and organic material of natural origin and restrictions on the patentability of antibodies. Such challenges, where compliance is necessary for the proper patent protection in Brazil, should be faced by companies under the guidance of patent experts.
At Daniel, our life sciences team covers both biotechnology and pharmaceutical inventions, due to the wide overlap of expertise of these two market industries. Besides specialized academic knowledge, work in this area requires employing a strategic position that takes into account the inevitable economic and social context in which decisions on pharmaceuticals are often taken.
In Brazil, the "Agência Nacional de Vigilância Sanitária" (ANVISA), which is the national health surveillance agency, has considerable power and influence in the patent sector. In addition, the generic drug industries have garnered great ability to enforce their interests. These are just two examples of how important it can be for companies to follow the advice of experts on patents, thereby avoiding risks that compromise their scientific and industrial investments.
Thank you for participating on the call today and please also thank your colleague. Without you both on the phone, we would never have been able to reach a conclusion.